Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
124 studies found for:    Open Studies | "Nasopharyngeal Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Avelumab for Recurrent/Metastatic Nasopharyngeal Cancer
Condition: Nasopharyngeal Cancer
Intervention: Drug: Avelumab
22 Recruiting Evaluation of the Sensitivity of Endoscopy to Detect Nasopharyngeal Carcinoma (NPC) in an Epstein-Barr Virus (EBV)-Based NPC Screening Project in China
Condition: Nasopharyngeal Cancinoma (NPC)
Intervention:
23 Recruiting Screening for Nasopharyngeal Carcinoma in High Risk Populations
Conditions: Nasopharyngeal Cancer;   Screening
Intervention:
24 Recruiting Chronomodulated Chemotherapy Followed by Concurrent Chemo-radiotherapy With IMRT in the Treatment of Advanced Nasopharyngeal Cancer
Condition: Esophageal Neoplasms [C06.405.117.430]
Interventions: Device: Chrono-chemotherapy pump:Melodie;   Device: Routine intravenous drip;   Drug: induction Chrono-chemotherapy;   Drug: induction Routine-chemotherapy;   Drug: cisplatin chrono-chemotherapy;   Drug: cisplatin routine-chemotherapy;   Radiation: intensity-modulated radiation therapy
25 Recruiting Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Ipilimumab;   Drug: Nivolumab
26 Recruiting Effect of the Plasma EBV DNA Change During Chemoradiotherapy in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Diagnostic Test: Plasma EBV DNA
27 Not yet recruiting IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Radiation: Intensity modulated radiotherapy;   Drug: Cisplatin
28 Recruiting Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Radiation: Radiotherapy alone;   Radiation: Concurrent chemoradiotherapy
29 Recruiting Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Nimotuzumab;   Radiation: Radiation
30 Not yet recruiting Prospective Study for Prognostic Biomarkers of Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Other: laboratory biomarker analysis
31 Not yet recruiting Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Carcinoma;   Children
Interventions: Drug: Paclitaxel;   Drug: Cisplatin;   Drug: 5-fu;   Radiation: Radical radiotherapy
32 Recruiting Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma
Condition: Locally Advanced Nasopharyngeal Carcinoma
Interventions: Drug: Docetaxel;   Drug: Cisplatin;   Radiation: IMRT/TOMO;   Drug: Chemotherapy
33 Recruiting EUS-FNA for Retropharyngeal Lymph Node (RPLN) in Recurrent Nasopharyngeal Carcinoma (NPC) Patients
Condition: Nasopharyngeal Carcinoma
Intervention: Procedure: EUS-FNA for RPLN in NPC patients
34 Recruiting Prognostic Analysis of Concurrent Chemoradiotherapy With/Without Adjuvant Chemotherapy for Locally Advanced NPC Patients
Condition: Local Advanced High Risk Nasopharyngeal Carcinoma
Interventions: Drug: IMRT combine with cisplatin concurrent chemotherapy;   Drug: IMRT combine with cisplatin concurrent chemotherapy plus capecitabine adjuvant chemotherapy
35 Recruiting Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: Capecitabine
36 Recruiting Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Conventional chemotherapy;   Drug: Maintenance chemotherapy 1;   Drug: Maintenance chemotherapy 2
37 Recruiting TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Other: Drug: Taxol,cisplatin and capecitabine;   Other: Drug: Cisplatin and 5-Fluorouracil
38 Not yet recruiting Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Endostar;   Drug: DDP
39 Recruiting A Phase II Trial of S-1 as Maintenance Treatment After Gemcitabine Plus Cisplatin Regimen Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma.
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: S-1
40 Recruiting Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: Cisplatin combine with IMRT

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.